A conversation with Keith Cannon, Director Product Management, Horizon Discovery Ltd.
Adoption of clinical genomics applications has been driven by increasingly scalable genomic technologies. Higher-throughput approaches to genetic testing have resulted in increased diagnostic yields and discovery coupled with advances in bioinformatic analysis tools.
Q&A with Patrick Hurban, Q2 Solutions
Sponsor: Bionano Genomics
Sponsor: IlluminaIn this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
Sponsor: Oxford NanoporeOxford Nanopore’s DNA/RNA sequencing technology delivers ultra-long reads (up to 2 Mb), enabling rapid and comprehensive analysis of variants. With devices scalable from portable to benchtop, nanopore sequencing offers a cost-effective solution to the challenges faced by traditional sequencing platforms.
Sponsored content brought to you by As genome sequencing technology advances, researchers are increasingly exploring emerging tools for a host of potential clinical applications. Andrew...
Sponsored content brought to you by What if every patient’s oncologist or lab testing personnel had access to an online digital encyclopedia of cancer mutations,...
Sponsor: TakedaTakeda has taken great strides in incorporating a patient-centric approach to drug development through the use of minimally invasive and less frequent testing procedures while maintaining the power and rigor of the clinical trial.
Sponsor: QiagenIn this webinar, we will describe Quest’s LeukoVantage assay, an NGS test designed specifically for detecting clinically relevant variants in myeloid malignancies, and its partnership with N-of-One, a QIAGEN company, for expert interpretation.